Generate BiomedicinesSomerville, Massachusetts, United States
Disclosure(s): Generate Biomedicines: Grant/Research Support, Stocks/Bonds (Private Company)
87 - Machine Learning-Guided Generation of a Potent Combination of Broadly Neutralizing Sarbecovirus Antibodies with a High Barrier to Resistance
Thursday, October 17, 202410:30 AM – 10:42 AM US PT